Analyte Concentration Measurement Device

• US 20090018416A1
• Filed: 07/13/2007
• Published: 01/15/2009
• Est. Priority Date: 07/13/2007
• Status: Abandoned Application

• Current Assignee: Nostix, LLC (Teleflex Incorporated)
• Original Assignee: Nostix, LLC (Teleflex Incorporated)
• Inventors: Dallmann, Devon J., Zellers, R. Dale, Repine, John E., Henry, Charles W., Nelson, Peter E., Walker, Stephen D.
• Application Number:
  US11/777,940
• Publication Number:
  US 20090018416A1
• Time in Patent Office: Days
• US Class Current: 600/316
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence

Abstract

A method for measuring concentration of an analyte in body fluid comprises acquiring a body fluid sample, emitting light into the body fluid sample, and detecting emitted light intensity on a plurality of optical paths through the body fluid sample. A plurality of optical filters are arranged in respective optical paths of the optical path plurality comprising at least a first optical filter with light absorption by an analyte and water and a second optical filter with light absorption to water alone. Light intensity passed through the first optical filter and passed through the second optical filter is measured and analyte concentration is determined based on a ratio of intensities detected at a detector in an optical path intersected by the first optical filter and detected at a detector in an optical path intersected by the second optical filter.

Claims

1. Analyte concentration measurement apparatus comprising:

a housing enclosing a sample chamber configured for holding a body fluid sample;

an emitter that emits light along an optical path into the sample chamber;

a detector positioned along the optical path across the sample chamber from the emitter that detects emitted light intensity;

a first optical filter with light absorption by an analyte and water;

a second optical filter with light absorption to water alone;

a switch that alternately interposes the first optical filter and the second optical filter into the optical path; and

a logic that determines the analyte concentration based on a ratio of intensities detected with the first optical filter and the second optical filter interposed into the optical path.

2. The apparatus according to claim 1 further comprising:

the apparatus comprising a glucose concentration measurement apparatus;

the first optical filter comprising a filter λ

1 with light absorption by glucose and water;

the second optical filter comprising a filter λ

2 with light absorption by water alone; and

the logic determines glucose concentration in the body fluid sample according to an equation as follows;

3. The apparatus according to claim 2 further comprising:

the first optical filter comprising a filter with a light absorption wavelength λ

1 of approximately 9.7 micrometers; and

the second optical filter comprising a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

4. The apparatus according to claim 2 further comprising:

the first optical filter comprising a filter with a light absorption wavelength λ

1 of approximately 9.0 micrometers; and

the second optical filter comprising a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

5. The apparatus according to claim 1 further comprising:

the housing enclosing a sample chamber configured for holding a body fluid sample comprising plasma, serum, saliva, cerebrospinal fluid, tears, urine, extracellular fluids, or other fluid from a body that does not contain red blood cells or hemoglobin.

6. The apparatus according to claim 1 further comprising:

the emitter configured to radiate broadband infrared light;

a parabolic reflector separated by an air gap from the emitter that collimates the radiated broadband infrared light; and

the housing, emitter, and detector arranged whereby optical path length is in an approximate range of 10-50 micrometers.

7. The apparatus according to claim 1 further comprising:

the switch comprising a sliding filter holder whereby light passes through a selected filters held by the sliding filter holder over the detector.

8. The apparatus according to claim 1 further comprising:

the first and second optical filters comprising narrowband filters with a center wavelength variability of ±

2%, a half power bandwidth of 0.12 micrometers, and peak transmission of 85%.

9. The apparatus according to claim 1 further comprising:

the housing enclosing the sample chamber is formed of a material that is nonabsorbent to 8-10 micrometer light and is sufficiently rigid to maintain 0-50 micrometer spacing, and remains solid when contacted by body fluid.

10. The apparatus according to claim 1 further comprising:

the housing enclosing the sample chamber is formed of high density polyethylene (HDPE) that has a transmission of approximately 53% at approximately 8.4 and 9.0 micrometers, and approximately 64% at approximately 9.7 micrometers.

11. A method for measuring concentration of an analyte in body fluid comprising:

acquiring a body fluid sample;

emitting light along an optical path into the body fluid sample;

detecting emitted light intensity on the optical path through the body fluid sample;

positioning a first optical filter with light absorption by an analyte and water in the optical path;

measuring the detected light intensity passed through the first optical filter;

replacing the first optical filter with a second optical filter with light absorption to water alone;

measuring the detected light intensity passed through the second optical filter;

determining analyte concentration based on a ratio of intensities detected with the first optical filter and the second optical filter interposed into the optical path.

12. The method according to claim 11 further comprising:

measuring glucose concentration in body fluid;

positioning the first optical filter comprising a filter λ

1 with light absorption by glucose and water;

replacing the first optical filter with the second optical filter comprising a filter λ

2 with light absorption by water alone; and

determining glucose concentration in the body fluid sample according to an equation as follows;

13. The method according to claim 12 further wherein:

the first optical filter comprises a filter with a light absorption wavelength λ

1 of approximately 9.7 micrometers; and

the second optical filter comprises a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

14. The method according to claim 12 wherein:

the first optical filter comprises a filter with a light absorption wavelength λ

1 of approximately 9.0 micrometers; and

the second optical filter comprises a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

15. The method according to claim 11 further comprising:

acquiring the body fluid sample comprising plasma, serum, saliva, cerebrospinal fluid, tears, urine, extracellular fluids, or other fluid from a body that does not contain red blood cells or hemoglobin.

16. Analyte concentration measurement apparatus comprising:

a housing enclosing a sample chamber configured for holding a body fluid sample;

an emitter that emits light into the sample chamber;

a plurality of detectors positioned along optical paths across the sample chamber from the emitter that detect emitted light intensity;

a plurality of optical filters aligned in respective optical paths of the detector plurality comprising at least a first optical filter with light absorption by an analyte and water and a second optical filter with light absorption to water alone; and

a logic that determines the analyte concentration based on a ratio of intensities detected at a first detector in an optical path intersected by the first optical filter and detected at a second detector in an optical path intersected by the second optical filter.

17. The apparatus according to claim 16 further comprising:

the apparatus comprising a glucose concentration measurement apparatus;

the first optical filter comprising a filter λ

1 with light absorption by glucose and water;

the second optical filter comprising a filter λ

2 with light absorption by water alone; and

the logic determines glucose concentration in the body fluid sample according to an equation as follows;

18. The apparatus according to claim 17 further comprising:

the first optical filter comprising a filter with a light absorption wavelength λ

1 of approximately 9.7 micrometers; and

the second optical filter comprising a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

19. The apparatus according to claim 17 further comprising:

the first optical filter comprising a filter with a light absorption wavelength λ

1 of approximately 9.0 micrometers; and

the second optical filter comprising a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

20. The apparatus according to claim 16 further comprising:

the housing enclosing a sample chamber configured for holding a body fluid sample comprising plasma, serum, saliva, cerebrospinal fluid, tears, urine, extracellular fluids, or other fluid from a body that does not contain red blood cells or hemoglobin.

21. The apparatus according to claim 16 further comprising:

the emitter configured to radiate broadband infrared light;

a parabolic reflector separated by an air gap from the emitter that collimates the radiated broadband infrared light; and

the housing, emitter, and detectors arranged whereby optical path lengths are in an approximate range of 10-50 micrometers.

22. The apparatus according to claim 16 further comprising:

the first and second optical filters comprising narrowband filters with a center wavelength variability of ±

2%, a half power bandwidth of 0.12 micrometers, and peak transmission of 85%.

23. The apparatus according to claim 16 further comprising:

the housing enclosing the sample chamber is formed of a material that is nonabsorbent to 8-10 micrometer light and is sufficiently rigid to maintain 0-50 micrometer spacing, and remains solid when contacted by body fluid.

24. The apparatus according to claim 16 further comprising:

the housing enclosing the sample chamber is formed of high density polyethylene (HDPE) that has a transmission of approximately 53% at approximately 8.4 and 9.0 micrometers, and approximately 64% at approximately 9.7 micrometers.

25. A method for measuring concentration of an analyte in body fluid comprising:

acquiring a body fluid sample;

emitting light into the body fluid sample;

detecting emitted light intensity on a plurality of optical paths through the body fluid sample;

arranging a plurality of optical filters in respective optical paths of the optical path plurality comprising at least a first optical filter with light absorption by an analyte and water and a second optical filter with light absorption to water alone;

measuring the detected light intensity passed through the first optical filter;

measuring the detected light intensity passed through the second optical filter;

determining analyte concentration based on a ratio of intensities detected at a detector in an optical path intersected by the first optical filter and detected at a detector in an optical path intersected by the second optical filter.

26. The method according to claim 25 further comprising:

measuring glucose concentration in body fluid;

arranging the optical filters including the first optical filter comprising a filter λ

1 with light absorption by glucose and water, and the second optical filter comprising a filter λ

2 with light absorption by water alone; and

determining glucose concentration in the body fluid sample according to an equation as follows;

27. The method according to claim 26 further wherein:

the first optical filter comprises a filter with a light absorption wavelength λ

1 of approximately 9.7 micrometers; and

the second optical filter comprises a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

28. The method according to claim 26 wherein:

the first optical filter comprises a filter with a light absorption wavelength λ

1 of approximately 9.0 micrometers; and

the second optical filter comprises a filter with a light absorption wavelength λ

2 of approximately 8.4 micrometers.

29. The method according to claim 25 further comprising:

acquiring the body fluid sample comprising plasma, serum, saliva, cerebrospinal fluid, tears, urine, extracellular fluids, or other fluid from a body that does not contain red blood cells or hemoglobin.